Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) EPS (Weighted Average and Diluted) (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.18 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) rose 82.52% year-over-year to -$0.18, compared with a TTM value of -$1.49 through Jun 2025, up 95.79%, and an annual FY2024 reading of -$6.63, up 78.09% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.18 for Q2 2025 at SeaStar Medical Holding, up from -$0.44 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.23 in Q4 2024 and bottomed at -$25.52 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$4.15, with a median of -$1.06 recorded in 2024.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 105.61% in 2024, while the deepest fall reached 775.93% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$4.1 in 2023, then skyrocketed by 105.61% to $0.23 in 2024, then plummeted by 178.26% to -$0.18 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ICU at -$0.18 in Q2 2025, -$0.44 in Q1 2025, and $0.23 in Q4 2024.